Your browser doesn't support javascript.
loading
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Urwyler, Pascal; Leimbacher, Marina; Charitos, Panteleimon; Moser, Stephan; Heijnen, Ingmar A F M; Trendelenburg, Marten; Thoma, Reto; Sumer, Johannes; Camacho-Ortiz, Adrián; Bacci, Marcelo R; Huber, Lars C; Stüssi-Helbling, Melina; Albrich, Werner C; Sendi, Parham; Osthoff, Michael.
Afiliação
  • Urwyler P; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Leimbacher M; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Charitos P; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Moser S; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Heijnen IAFM; Division of Medical Immunology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
  • Trendelenburg M; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Thoma R; Department of Clinical Research, University of Basel, Basel, Switzerland.
  • Sumer J; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Camacho-Ortiz A; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Bacci MR; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Huber LC; Servicio de Infectologia, Hospital Universitario Dr. José Eleuterio González, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
  • Stüssi-Helbling M; Department of General Practice, Centro Universitário em Saúde do ABC, Santo André, Brazil.
  • Albrich WC; Clinic for Internal Medicine, City Hospital Triemli, Zurich, Switzerland.
  • Sendi P; Clinic for Internal Medicine, City Hospital Triemli, Zurich, Switzerland.
  • Osthoff M; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Front Immunol ; 14: 1255292, 2023.
Article em En | MEDLINE | ID: mdl-37965347

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / COVID-19 Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / COVID-19 Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article